Search Results

There are 11270 results for: content related to: AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney

  1. You have free access to this content
    Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib – the role of extracellular signal-regulated kinase counteraction

    The FEBS Journal

    Volume 278, Issue 18, September 2011, Pages: 3494–3507, Irena Manov, Yulia Pollak, Rinata Broneshter and Theodore C. Iancu

    Version of Record online : 5 SEP 2011, DOI: 10.1111/j.1742-4658.2011.08271.x

  2. You have free access to this content
    Interim analysis of START: Study in asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial

    International Journal of Cancer

    Volume 132, Issue 10, 15 May 2013, Pages: 2448–2458, Young-Hwa Chung, Guohong Han, Jung-Hwan Yoon, Jijin Yang, Jianhua Wang, Guo-Liang Shao, Byung Ik Kim, Teng-Yu Lee and Yee Chao

    Version of Record online : 28 NOV 2012, DOI: 10.1002/ijc.27925

  3. You have free access to this content
    ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21(CIP1/WAF1) in human cancer cells

    British Journal of Pharmacology

    Volume 171, Issue 13, July 2014, Pages: 3182–3195, Jingru Li, Yicheng Chen, Jiali Wan, Xin Liu, Chunrong Yu and Wenhua Li

    Version of Record online : 10 JUN 2014, DOI: 10.1111/bph.12659

  4. Sorafenib combined vitamin K induces apoptosis in human pancreatic cancer cell lines through RAF/MEK/ERK and c-Jun NH2-terminal kinase pathways

    Journal of Cellular Physiology

    Volume 224, Issue 1, July 2010, Pages: 112–119, Gang Wei, Meifang Wang and Brian I. Carr

    Version of Record online : 18 MAR 2010, DOI: 10.1002/jcp.22099

  5. You have free access to this content
    The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: Final results of the START trial

    International Journal of Cancer

    Volume 136, Issue 6, 15 March 2015, Pages: 1458–1467, Yee Chao, Young-Hwa Chung, Guohong Han, Jung-Hwan Yoon, Jijin Yang, Jianhua Wang, Guo-Liang Shao, Byung Ik Kim and Teng-Yu Lee

    Version of Record online : 16 SEP 2014, DOI: 10.1002/ijc.29126

  6. You have free access to this content
    Incidence and Risk of Sorafenib-Induced Hypertension: A Systematic Review and Meta-Analysis

    The Journal of Clinical Hypertension

    Volume 16, Issue 3, March 2014, Pages: 177–185, Yan Li, Shun Li, Yaofeng Zhu, Xinyue Liang, Hui Meng, Jun Chen, Dongqing Zhang, Hu Guo and Benkang Shi

    Version of Record online : 12 MAR 2014, DOI: 10.1111/jch.12273

  7. You have full text access to this Open Access content
    Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma

    Journal of Cellular and Molecular Medicine

    Volume 13, Issue 8b, August 2009, Pages: 2673–2683, Hung Huynh, Van Chanh Ngo, Heng Nung Koong, Donald Poon, Su Pin Choo, Choon Hua Thng, Pierce Chow, Hock Soo Ong, Alexander Chung and Khee Chee Soo

    Version of Record online : 11 FEB 2009, DOI: 10.1111/j.1582-4934.2009.00692.x

  8. Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC

    Liver International

    Volume 35, Issue 2, February 2015, Pages: 620–626, Jens Ricke, Karsten Bulla, Frank Kolligs, Markus Peck-Radosavljevic, Peter Reimer, Bruno Sangro, Eckart Schott, Kerstin Schütte, Chris Verslype, Jerzy Walecki, Peter Malfertheiner and for the SORAMIC study group

    Version of Record online : 8 JUL 2014, DOI: 10.1111/liv.12622

  9. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  10. You have free access to this content
    Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo

    International Journal of Cancer

    Volume 127, Issue 12, 15 December 2010, Pages: 2949–2958, Gang Wei, Meifang Wang, Terry Hyslop, Ziqiu Wang and Brian I. Carr

    Version of Record online : 7 JUN 2010, DOI: 10.1002/ijc.25498

  11. You have free access to this content
    Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO-AB 31/05)

    BJU International

    Volume 113, Issue 3, March 2014, Pages: 429–436, Susanne Krege, Heidrun Rexer, Frank vom Dorp, Patrick de Geeter, Theodor Klotz, Margitte Retz, Axel Heidenreich, Michael Kühn, Joern Kamradt, Susan Feyerabend, Christian Wülfing, Stefan Zastrow, Peter Albers, Oliver Hakenberg, Jan Roigas, Martin Fenner, Hans Heinzer and Mark Schrader

    Version of Record online : 14 FEB 2014, DOI: 10.1111/bju.12437

  12. Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 12, December 2014, Pages: 2021–2031, Da-Liang Ou, Chun-Jung Chang, Yung-Ming Jeng, Yi-Jang Lin, Zhong-Zhe Lin, Anita K Gandhi, Sheng-Chieh Liao, Zi-Ming Huang, Chiun Hsu and Ann-Lii Cheng

    Version of Record online : 18 NOV 2014, DOI: 10.1111/jgh.12708

  13. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma

    Intervention Review

    The Cochrane Library

    Omar M Abdel-Rahman and Zeinab Elsayed

    Published Online : 16 FEB 2016, DOI: 10.1002/14651858.CD011313.pub2

  14. Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 12, December 2013, Pages: 1834–1841, Daisuke Miyaki, Hiroshi Aikata, Hiromi Kan, Hatsue Fujino, Ayako Urabe, Keiichi Masaki, Takayuki Fukuhara, Tomoki Kobayashi, Noriaki Naeshiro, Takashi Nakahara, Tomokazu Kawaoka, Akira Hiramatsu, Shoichi Takahashi, Masaki Ishikawa, Hideaki Kakizawa, Kazuo Awai and Kazuaki Chayama

    Version of Record online : 22 NOV 2013, DOI: 10.1111/jgh.12311

  15. You have full text access to this OnlineOpen article
    Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation

    International Journal of Cancer

    Volume 136, Issue 6, 15 March 2015, Pages: 1434–1444, Floris H. Groenendijk, Wouter W. Mellema, Eline van der Burg, Eva Schut, Michael Hauptmann, Hugo M. Horlings, Stefan M. Willems, Michel M. van den Heuvel, Jos Jonkers, Egbert F. Smit and René Bernards

    Version of Record online : 8 AUG 2014, DOI: 10.1002/ijc.29113

  16. You have free access to this content
    A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment options

    BJU International

    Volume 107, Issue 8, April 2011, Pages: 1190–1199, Joaquim Bellmunt, Tim Eisen, Cezary Szczylik, Peter Mulders and Camillo Porta

    Version of Record online : 15 NOV 2010, DOI: 10.1111/j.1464-410X.2010.09829.x

  17. You have full text access to this OnlineOpen article
    FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity

    Pharmacology Research & Perspectives

    Volume 3, Issue 5, October 2015, Dilruba Ahmed, Petra J. de Verdier, Charlotta Ryk, Oscar Lunqe, Per Stål and Jenny Flygare

    Version of Record online : 19 AUG 2015, DOI: 10.1002/prp2.171

  18. Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open-label, single-arm phase II study

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue 3, September 2014, Pages: 255–260, Vichien Srimuninnimit, Virote Sriuranpong and Suthida Suwanvecho

    Version of Record online : 9 MAY 2014, DOI: 10.1111/ajco.12191

  19. You have free access to this content
    Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib

    Hepatology

    Volume 56, Issue 6, December 2012, Pages: 2363–2374, Carlo Spirli, Carola M. Morell, Luigi Locatelli, Stefano Okolicsanyi, Cecilia Ferrero, Amy K. Kim, Luca Fabris, Romina Fiorotto and Mario Strazzabosco

    Version of Record online : 27 AUG 2012, DOI: 10.1002/hep.25872

  20. You have free access to this content
    Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen–positive myeloid cell infiltration in mice

    Hepatology

    Volume 59, Issue 4, April 2014, Pages: 1435–1447, Yunching Chen, Yuhui Huang, Thomas Reiberger, Annique M. Duyverman, Peigen Huang, Rekha Samuel, Lotte Hiddingh, Sylvie Roberge, Christina Koppel, Gregory Y. Lauwers, Andrew X. Zhu, Rakesh K. Jain and Dan G. Duda

    Version of Record online : 18 FEB 2014, DOI: 10.1002/hep.26790